Press Releases

  August 15, 2018
NEW STORY CEL-SCI Reports Recent Data Review By the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study
  August 14, 2018
NEW STORY CEL-SCI Corporation Reports Third Quarter Fiscal Year 2018 Financial Results
  July 13, 2018
NEW STORY CEL-SCI Reports on NYSE American Noncompliance Notice and Compliance Plan
  July 9, 2018
NEW STORY CEL-SCI Corporatiom Issues Letter to Shareholders
  July 2, 2018
NEW STORY CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering
  June 28, 2018
NEW STORY CEL-SCI Announces $5 Million Registered Direct Offering
  June 27, 2018
NEW STORY CEL-SCI Receives $2.1 Million from Warrant Exercises
  June 27, 2018
NEW STORY CEL-SCI Wins Breach of Contract Ruling Against Clinical Research Organization inVentiv, Now Known as Syneos Health
  June 11, 2018
CEL-SCI Corporation Issues Letter to Shareholders
  June 8, 2018
U.S. Patent Office Allows New CEL-SCI Patents for LEAPS Vaccine Platform Technology
  May 30, 2018
CEL-SCI Announces Reminder of Warrant Exercise Price
  May 22, 2018
CEL-SCI Corporation to Present at the 8th annual LD Micro Invitational
  May 15, 2018
CEL-SCI Corporation Reports Second Quarter Fiscal 2018 Financial Results
  May 2, 2018
CEL-SCI Corporation Announces Upcoming Investor Conference Presentations
  April 9, 2018
CEL-SCI Corporation to Present at The Microcap Conference
  April 4, 2018
CEL-SCI Issues Letter to Shareholders
  April 3, 2018
CEL-SCI Announces Adjustment to Warrant Exercise Price
  February 23, 2018
CEL-SCI Extends the Expiration Date of Series DD and Series EE Warrants Issued In December 2016
  February 12, 2018
CEL-SCI Corporation Reports First Quarter Fiscal 2018 Financial Results
  February 12, 2018
CEL-SCI to Present Tomorrow at 2018 BIO CEO & Investor Conference
  February 5, 2018
CEL-SCI to Present at 2018 BIO CEO & Investor Conference
  January 30, 2018
U.S. Patent Office Allows New CEL-SCI Patent For LEAPS Vaccine Platform Technology
  January 16, 2018
CEL-SCI Announces Adjustment to Warrant Exercise Price
  January 8, 2018
CEL-SCI Awarded Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis
  January 3, 2018
CEL-SCI Issues Letter to Shareholders

Press Releases - 2017

Press Releases - 2016

Press Releases - 2015

Press Releases - 2014

Press Releases - 2013

Press Releases - 2012

Press Releases - 2011